Novel fatty acid-based pH-responsive nanostructured lipid carriers for enhancing antibacterial delivery

The present study is aimed at the employment of novel fatty acid derived lipids for the preparation of pH-responsive nanostructured lipid carriers (NLCs) for vancomycin (VCM) intravenous delivery against resistant and sensitive Staphylococcus aureus bacteria. Two branched lipids [stearic ‏acid deriv...

Full description

Saved in:
Bibliographic Details
Published inJournal of drug delivery science and technology Vol. 53; p. 101125
Main Authors Osman, Nawras, Omolo, Calvin A., Gannimani, Ramesh, Waddad, Ayman Y., Rambharose, Sanjeev, Mocktar, Chunderika, Singh, Sanil, Parboosing, Raveen, Govender, Thirumala
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.10.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present study is aimed at the employment of novel fatty acid derived lipids for the preparation of pH-responsive nanostructured lipid carriers (NLCs) for vancomycin (VCM) intravenous delivery against resistant and sensitive Staphylococcus aureus bacteria. Two branched lipids [stearic ‏acid derived solid lipid and oleic acid derived liquid lipid‏] were synthesized, characterized and used to fabricate NLCs by hot homogenization technique. Particle size, ‏polydispersity index, zeta potential and encapsulation efficiency were 225.2 ± 9.1 nm, 0.258 ± 0.02, −9.2 ± 2.7 mV and 88.7 ± 13.12%, respectively. An understanding of drug encapsulation efficiencies and formation of the NLCs were supported by in silico studies. In vitro antibacterial activity revealed ‏that‏ VCM loaded-NLCs had higher activity against methicillin-susceptible and resistant Staphylococcus aureus than the bare VCM. Cell viability study showed that NLCs had 2.5-fold better killing percentage than the bare drug at similar concentrations. Furthermore, the in vivo efficacy of VCM loaded-NLCs was assessed in a mouse model of MRSA skin infection. MRSA CFU load of the skin treated with NLCs was 37-fold lower than bare VCM (p < 0.05). This novel pH-responsive NLCs may, therefore, show potential for efficient and enhanced antibiotic delivery. [Display omitted]
ISSN:1773-2247
DOI:10.1016/j.jddst.2019.101125